Priority Date: 15.11.11 (US 201161559864P)

MEDICINE FOR TREATMENT AND/OR IMPROVEMENT OF SEPSIS

  • Application ID: EP12850047
  • Status: EXAMINATION IN PROGRESS

Applicant

Technology company logo small
Technology Company

Attorney

Employment test 201 - 500 employees
Company dna grunecker kinkeldey stockmair and schwanhausser
operating since 1924
Headquarter in Munich and 2 offices
active in Legal Services

Specialization

This EP application has the IPC combination A61 (MEDICAL OR VETERINARY SCIENCE; HYGIENE) and C12 (BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING). We found, that TransMIT GmbH, Kailuweit & Uhlemann, Sperling Fischer & Heyner, Zacco, Lederer Keller Patentanwälte Partnerschaft mbB and 184 others are specialized in this combination either. For a similar patent, they might be a good choice.

Timeline

  • 15.11.2011 - Priority Date (US 201161559864P)
  • 23.05.2013 - Publication A1 (WO2013073545)
  • 24.09.2014 - Publication A1 (EP2781221)

IPC Classification